Literature DB >> 23794114

Genetic variants associated with insulin signaling and glucose homeostasis in the pathogenesis of insulin resistance in polycystic ovary syndrome: a systematic review.

Bhaskar Venkata Kameswara Subrahmanya Lakkakula1, Maheswari Thangavelu, Usha Rani Godla.   

Abstract

BACKGROUND: Polycystic ovary syndrome must be recognized as a serious issue due to its implication on long term health regardless of an individual's age. PCOS and insulin resistance are interlinked, as approximately 40 % of women with PCOS are insulin resistant. However, the detailed molecular basis for insulin resistance that is coupled with PCOS remains poorly understood.
OBJECTIVE: To review the published evidence that polymorphisms in genes that are involved in insulin secretion and action are associated with an increased risk of PCOS.
METHODS: We reviewed articles published through November 2012 which concerned polymorphisms of genes related to insulin signaling and glucose homeostasis as well as their associations with PCOS. The articles were identified via Medline searches.
CONCLUSIONS: No consistent evidence emerged of a strong association between the risk of PCOS and any known gene that is related to insulin signaling and glucose homeostasis. Moreover, recent genome-wide association studies are inconsistent in identifying the associations between PCOS and insulin metabolism genes. Many of the studies reviewed were limited by heterogeneity in the PCOS diagnosis and by not have having a sufficient number of study participants. Further studies are warranted to determine predisposing risk factors which could modify environmental factors and thus reduce the risk of PCOS. Large genome-wide association studies devoted solely to PCOS will be necessary to identify new candidate genes and proteins that are involved in PCOS risk.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23794114      PMCID: PMC3725227          DOI: 10.1007/s10815-013-0030-1

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  179 in total

1.  The human insulin receptor cDNA: the structural basis for hormone-activated transmembrane signalling.

Authors:  Y Ebina; L Ellis; K Jarnagin; M Edery; L Graf; E Clauser; J H Ou; F Masiarz; Y W Kan; I D Goldfine
Journal:  Cell       Date:  1985-04       Impact factor: 41.582

2.  Genetic variants in peroxisome proliferator-activated receptor gamma influence insulin resistance and testosterone levels in normal women, but not those with polycystic ovary syndrome.

Authors:  Heath J Antoine; Marita Pall; Belynda C Trader; Yii-Der I Chen; Ricardo Azziz; Mark O Goodarzi
Journal:  Fertil Steril       Date:  2006-12-04       Impact factor: 7.329

3.  Peroxisome proliferator-activated receptor-γ and -δ polymorphisms in women with polycystic ovary syndrome.

Authors:  P Christopoulos; G Mastorakos; M Gazouli; E Deligeoroglou; I Katsikis; E Diamanti-Kandarakis; D Panidis; G Creatsas
Journal:  Ann N Y Acad Sci       Date:  2010-09       Impact factor: 5.691

4.  A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance.

Authors:  L J Baier; P A Permana; X Yang; R E Pratley; R L Hanson; G Q Shen; D Mott; W C Knowler; N J Cox; Y Horikawa; N Oda; G I Bell; C Bogardus
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

5.  Insulin resistance and hyperinsulinemia induce hyperandrogenism in a young type B insulin-resistant female.

Authors:  T J DeClue; S C Shah; M Marchese; J I Malone
Journal:  J Clin Endocrinol Metab       Date:  1991-06       Impact factor: 5.958

6.  Relationship of calpain-10 genotype to phenotypic features of polycystic ovary syndrome.

Authors:  David A Ehrmann; Peter E H Schwarz; Manami Hara; Xu Tang; Yukio Horikawa; Jacqueline Imperial; Graeme I Bell; Nancy J Cox
Journal:  J Clin Endocrinol Metab       Date:  2002-04       Impact factor: 5.958

7.  Precocious pubarche, hyperinsulinism, and ovarian hyperandrogenism in girls: relation to reduced fetal growth.

Authors:  L Ibáñez; N Potau; I Francois; F de Zegher
Journal:  J Clin Endocrinol Metab       Date:  1998-10       Impact factor: 5.958

8.  Relationship of insulin receptor substrate-1 and -2 genotypes to phenotypic features of polycystic ovary syndrome.

Authors:  David A Ehrmann; Xu Tang; Issei Yoshiuchi; Nancy J Cox; Graeme I Bell
Journal:  J Clin Endocrinol Metab       Date:  2002-09       Impact factor: 5.958

9.  Association between the Pro12Ala polymorphism of PPAR-γ gene and the polycystic ovary syndrome: a meta-analysis of case-control studies.

Authors:  Hong Zhang; Yan Bi; Changjun Hu; Weiping Lu; Dalong Zhu
Journal:  Gene       Date:  2012-05-04       Impact factor: 3.688

10.  The CAPN10 gene is associated with insulin resistance phenotypes in the Spanish population.

Authors:  María E Sáez; José L González-Sánchez; Reposo Ramírez-Lorca; María T Martínez-Larrad; Carina Zabena; Alejandro González; Francisco J Morón; Agustín Ruiz; Manuel Serrano-Ríos
Journal:  PLoS One       Date:  2008-08-13       Impact factor: 3.240

View more
  8 in total

1.  Glucose, insulin, and cortisol concentrations and glucose tolerance test in Holstein cows with inactive ovaries.

Authors:  Reza Azarbayejani; Majid Mohammadsadegh
Journal:  Trop Anim Health Prod       Date:  2020-11-24       Impact factor: 1.559

Review 2.  Insulin: its role in the central control of reproduction.

Authors:  Joanna H Sliwowska; Chrysanthi Fergani; Monika Gawałek; Bogda Skowronska; Piotr Fichna; Michael N Lehman
Journal:  Physiol Behav       Date:  2014-05-27

Review 3.  The Treatment with Complementary and Alternative Traditional Chinese Medicine for Menstrual Disorders with Polycystic Ovary Syndrome.

Authors:  Yuehui Zhang; Xiaozhu Guo; Shuting Ma; Haoyue Ma; Hang Li; Yi Wang; Zhen Qin; Xiaoke Wu; Yaguang Han; Yanhua Han
Journal:  Evid Based Complement Alternat Med       Date:  2021-05-17       Impact factor: 2.629

Review 4.  New insights into the genetic basis of infertility.

Authors:  Thejaswini Venkatesh; Padmanaban S Suresh; Rie Tsutsumi
Journal:  Appl Clin Genet       Date:  2014-12-01

5.  Acupuncture treatment for insulin sensitivity of women with polycystic ovary syndrome and insulin resistance: a study protocol for a randomized controlled trial.

Authors:  Juan Li; Ernest Hung Yu Ng; Elisabet Stener-Victorin; Zhenxing Hu; Xiaoguang Shao; Haiyan Wang; Meifang Li; Maohua Lai; Changcai Xie; Nianjun Su; Chuyi Yu; Jia Liu; Taixiang Wu; Hongxia Ma
Journal:  Trials       Date:  2017-03-09       Impact factor: 2.279

6.  Possible Link Between Stress-related Factors and Altered Body Composition in Women with Polycystic Ovarian Syndrome.

Authors:  Barnali Ray Basu; Olivia Chowdhury; Sudip Kumar Saha
Journal:  J Hum Reprod Sci       Date:  2018 Jan-Mar

7.  Paeoniflorin attenuates DHEA-induced polycystic ovary syndrome via inactivation of TGF-β1/Smads signaling pathway in vivo.

Authors:  Jie Zhou; Yong Tan; Xudong Wang; Meihong Zhu
Journal:  Aging (Albany NY)       Date:  2021-02-26       Impact factor: 5.682

8.  Effect of Wenshentiaojing Decoction on Hormone Level and Follicular Number in Patients with Menstrual Disorder of Polycystic Ovary Syndrome.

Authors:  Lanzhi Li; Ning Huang; Yanyan Qi; Yan Li; Lu Wang
Journal:  Evid Based Complement Alternat Med       Date:  2021-11-29       Impact factor: 2.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.